Jeffrey Vacirca, MD

Chairman of the Board & CEO
New York Cancer & Blood Specialists

Jeffrey Vacirca, MD, FACP, is a renowned cancer physician and visionary leader with extensive experience and commitment to community oncology.

Dr. Vacirca assumed the role of CEO and Chairman of the Board of New York Cancer & Blood Specialists (NYCBS) in 2008. After two years, the practice emerged as a stronger unified group of physicians dedicated to reinventing themselves as the premier cancer care deliverers of New York.

He has led NYCBS through an unparalleled period of transformation and incredible growth to grow into the leading oncology practice that now sees nearly a million patients a year throughout more than 30 oncology locations and 35 hospital affiliations.

Dr. Vacirca takes action against key billings, including abuse of pharmacy benefit managers (PBMs) and sequester cuts. He formed the Conquering Cancer PAC, which advocates for cancer patients and, most importantly, strives to ensure access and availability for all patients no matter where they live.

Dr. Vacirca is the past president of the Community Oncology Alliance (COA) and continues to be a member of their executive committee. He is a co-founder and board member of OneOncology and serves on the board of directors of Assertio Therapeutics, Inc. and the American Red Cross of Greater New York. Most of his roles in these remarkable companies focus on legislative advocacy for the cost of cancer care and access.

Additionally, Dr. Vacirca serves as a Scientific Advisory Board Member for Caris Life Sciences and is president and co-founder of the National Translational Research Group. He has been part of early funding for some remarkable companies, including Cedar, Thyme Care, and Sherpa Health. In 2016, Dr. Vacirca co-founded Odonate Therapeutics.

Dr. Vacirca is the medical director for Oncology Network Development at Mt. Sinai Health Network and Long Island Aids Care (LIAAC). He serves on the board of directors for PatientPoint and Annexus Health. Previously, Dr. Vacirca served on the board of Spectrum Pharmaceuticals and as the medical director for the International Oncology Network, part of AmerisourceBergen, where he was part of their contracting advisory board for almost 15 years.

In 2014, Dr. Vacirca founded the New York Cancer Foundation, which provides financial assistance to patients undergoing treatment for cancer. He serves as Chairman of the Board.

Dr. Vacirca has received honors such as Humanitarian of the Year by the American Red Cross and its Corporate Leadership Award on behalf of NYCBS. He was awarded the Red Door Award for Leadership and Cancer Advocacy by the Red Door Community and received the Founder’s Medalist by The Brooklyn Hospital. Dr. Vacirca also received the Theodore Roosevelt Award for outstanding dedication to patient care and was named Newsday’s Top Doctor. He has also been honored for his role in enabling the Long Island Association for AIDS Care staff to bring state-of-the-art HIV testing to New York. In 2023, the Long Island Herald recognized him as a Top Chief Officer.